Group 1 - The core viewpoint of the news is that Morning Light Bio has seen a stock price increase of 5.07%, reaching 13.26 CNY per share, with a total market capitalization of 6.406 billion CNY [1] - Morning Light Bio, established on April 12, 2000, and listed on November 5, 2010, specializes in the research, production, and sales of natural plant extracts, including chili red pigment, lutein, chili oil resin, lycopene, and cottonseed protein [1] - The company's main business revenue composition is as follows: cottonseed-related business accounts for 48.25%, pigment/spice/nutritional and medicinal products account for 47.39%, and others account for 4.35% [1] Group 2 - From the perspective of fund holdings, one fund under China Europe Fund has a significant position in Morning Light Bio, with the China Europe Value Selection Mixed A Fund holding 581,300 shares, representing 2.43% of the fund's net value [2] - The China Europe Value Selection Mixed A Fund has achieved a year-to-date return of 22.87% and a one-year return of 39.76%, ranking 4202 out of 8171 and 3898 out of 8004 respectively [2] - The fund manager, Zhang Xueming, has been in position for 1 year and 157 days, with the fund's total asset size at 1.711 billion CNY and the best return during his tenure being 70.87% [3]
晨光生物股价涨5.07%,中欧基金旗下1只基金重仓,持有58.13万股浮盈赚取37.2万元